A review of possible therapies for multiple sclerosis
Hui Li,Gaojian Lian,Guang Wang,Qianmei Yin,Zehong Su
DOI: https://doi.org/10.1007/s11010-021-04119-z
IF: 3.842
2021-04-22
Molecular and Cellular Biochemistry
Abstract:Multiple sclerosis (MS) is an autoimmune chronic inflammatory disease of the central nervous system with a wide range of symptoms, like executive function defect, cognitive dysfunction, blurred vision, decreased sensation, spasticity, fatigue, and other symptoms. This neurological disease is characterized by the destruction of the blood–brain barrier, loss of myelin, and damage to neurons. It is the result of immune cells crossing the blood–brain barrier into the central nervous system and attacking self-antigens. Heretofore, many treatments proved that they can retard the progression of the disease even though there is no cure. Therefore, treatments aimed at improving patients' quality of life and reducing adverse drug reactions and costs are essential. In this review, the treatment approaches to alleviate the progress of MS include the following: pharmacotherapy, antibody therapy, cell therapy, gene therapy, and surgery. The current treatment methods of MS are described in terms of the prevention of myelin shedding, the promotion of myelin regeneration, and the protection of neurons.
cell biology